Total Payments
$4,795
2023 Payments
$109.67
Companies
21
Transactions
317
Payment Breakdown by Category
Food & Beverage$4,559 (95.1%)
Travel$230.30 (4.8%)
Education$5.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,559 | 312 | 95.1% |
| Travel and Lodging | $230.30 | 2 | 4.8% |
| Education | $5.70 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,333 | 106 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $807.77 | 48 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $603.81 | 56 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $484.94 | 6 | $0 (2017) |
| Shire North American Group Inc | $281.07 | 20 | $0 (2019) |
| Alkermes, Inc. | $270.34 | 18 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $269.48 | 21 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $179.60 | 6 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $81.82 | 5 | $0 (2022) |
| Indivior Inc. | $79.27 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $109.67 | 7 | Teva Pharmaceuticals USA, Inc. ($34.33) |
| 2022 | $676.36 | 37 | Teva Pharmaceuticals USA, Inc. ($145.27) |
| 2020 | $324.12 | 20 | Otsuka America Pharmaceutical, Inc. ($164.12) |
| 2019 | $1,120 | 99 | Otsuka America Pharmaceutical, Inc. ($327.52) |
| 2018 | $997.55 | 72 | Otsuka America Pharmaceutical, Inc. ($387.27) |
| 2017 | $1,567 | 82 | Novartis Pharmaceuticals Corporation ($484.94) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 2 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/10/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neuroscience | ||||||
| 08/08/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CNS | ||||||
| 08/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Neuroscience | ||||||
| 07/11/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: BH | ||||||
| 06/28/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/15/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuropsychiatry | ||||||
| 06/13/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/17/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Neuropsychiatry | ||||||
| 04/26/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.33 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CNS | ||||||
| 04/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuroscience | ||||||
| 04/12/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Neuropsychiatry | ||||||
| 04/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Neuroscience | ||||||
| 03/15/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/18/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROLOGY | ||||||
| 03/13/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: CNS | ||||||
| 03/05/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROLOGY | ||||||
| 03/02/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $80.98 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Ambreen Ahmed, MD
Dr. Ambreen Ahmed, MD is a Child & Adolescent Psychiatry healthcare provider based in Sullivan, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376655746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ambreen Ahmed, MD has received a total of $4,795 in payments from pharmaceutical and medical device companies, with $109.67 received in 2023. These payments were reported across 317 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,559).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Sullivan, MO
- Active Since 08/31/2006
- Last Updated 04/25/2018
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376655746
Products in Payments
- ABILIFY MAINTENA (Drug) $840.03
- LATUDA (Drug) $807.77
- REXULTI (Drug) $528.96
- FEVIPIPRANT (Drug) $484.94
- INVEGA SUSTENNA (Drug) $321.24
- INGREZZA (Drug) $269.48
- ARISTADA (Drug) $199.03
- AUSTEDO (Drug) $179.60
- VYVANSE (Drug) $175.09
- INVEGA TRINZA (Drug) $146.24
- SPRAVATO (Drug) $126.29
- MYDAYIS (Drug) $118.79
- Nuedexta (Drug) $81.82
- Aristada 441 mg (Drug) $71.31
- VRAYLAR (Drug) $68.87
- PERSERIS (Drug) $60.84
- CAPLYTA (Drug) $59.85
- Adzenys XR-ODT (Drug) $51.42
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $31.23
- Azstarys (Drug) $26.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.